Zobrazeno 1 - 10
of 58 503
pro vyhledávání: '"Response evaluation criteria in solid tumors"'
Autor:
Yuan Xu, Dongjie Ma, Yingzhi Qin, Shanqing Li, Ji Li, Ying Jiang, Mengzhao Wang, Yan Xu, Jing Zhao, Minjiang Chen, Wuying Cheng, Ke Hu, Hongsheng Liu
Publikováno v:
Thoracic Cancer, Vol 14, Iss 17, Pp 1635-1639 (2023)
Abstract Background Neoadjuvant immunotherapy combined with chemotherapy has been used to treat locally advanced non–small cell lung cancer (NSCLC). Several systems have been developed for response evaluation. The aim of this study was to evaluate
Externí odkaz:
https://doaj.org/article/ee71e7a2283645ed97731217a3734a1a
Autor:
Gouda MA; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston., Janku F; Monte Rosa Therapeutics, Boston, USA., Wahida A; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Buschhorn L; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Schneeweiss A; Division of Gynecological Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany., Abdel Karim N; Inova Schar Cancer Institute, Fairfax, (5)University of Virginia, Charlottesville., De Miguel Perez D; Center for Thoracic Oncology, Icahn School of Medicine at Mount Sinai, New York, USA., Del Re M; Center for Thoracic Oncology, Icahn School of Medicine at Mount Sinai, New York, USA., Russo A; Medical Oncology Unit, Papardo Civil Hospital and Department of Human Pathology, University of Messina, Messina., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, Milano; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milano, Italy., Rolfo C; Center for Thoracic Oncology, Icahn School of Medicine at Mount Sinai, New York, USA., Subbiah V; Sarah Cannon Research Institute, Nashville, USA. Electronic address: Vivek.subbiah@scri.com.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 267-275. Date of Electronic Publication: 2023 Dec 23.
Autor:
Huang Y; China National Biotec Group Company Limited, Beijing, China., Yang Y; China National Biotec Group Company Limited, Beijing, China., Qu A; Shanghai Institute of Biological Products Co. Ltd., Shanghai, China., Li S; China National Biotec Group Company Limited, Beijing, China., Chen D; Shanghai Institute of Biological Products Co. Ltd., Shanghai, China., Zou H; China National Biotec Group Company Limited, Beijing, China., Li S; China National Biotec Group Company Limited, Beijing, China., Zhang Y; China National Biotec Group Company Limited, Beijing, China., Zhuang W; China National Biotec Group Company Limited, Beijing, China., Su J; China National Biotec Group Company Limited, Beijing, China., Zhou X; Shanghai Institute of Biological Products Co. Ltd., Shanghai, China., Zhang Y; China National Biotec Group Company Limited, Beijing, China.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2024 Feb; Vol. 20 (1), pp. 101-108. Date of Electronic Publication: 2023 Oct 29.
Autor:
Luo C; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Huang W; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Li S; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Li H; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Ruan G; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Fu G; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Liu L; Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Radiology, The Third People's Hospital of Shenzhen, Shenzhen, China.
Publikováno v:
Head & neck [Head Neck] 2024 Oct; Vol. 46 (10), pp. 2540-2549. Date of Electronic Publication: 2024 Mar 28.
Autor:
Xu, Yuan1 (AUTHOR), Ma, Dongjie1 (AUTHOR), Qin, Yingzhi1 (AUTHOR), Li, Shanqing1 (AUTHOR), Li, Ji2 (AUTHOR), Jiang, Ying2 (AUTHOR), Wang, Mengzhao3 (AUTHOR), Xu, Yan3 (AUTHOR), Zhao, Jing3 (AUTHOR), Chen, Minjiang3 (AUTHOR), Cheng, Wuying4 (AUTHOR), Hu, Ke5 (AUTHOR), Liu, Hongsheng1 (AUTHOR) hongshengliu16@163.com
Publikováno v:
Thoracic Cancer. Jun2023, Vol. 14 Issue 17, p1635-1639. 5p.
Autor:
Ming-Yu Lai, Shi-Yang Kang, Yu-Ting Sun, Ting-Ting Quan, Shi-Xun Lu, Cai-Yun He, Zhi-Wei Zhou, Li-Qiong Yang, Hui-Yan Luo, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu, Wen-Long Guan, Miao-Zhen Qiu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Both Response Evaluation Criteria in Solid Tumors (RECIST) and tumor regression grade (TRG) play key roles in evaluating tumor response. We analyzed the consistency of TRG and RECIST 1.1 for gastric cancer (GC) patients and compar
Externí odkaz:
https://doaj.org/article/a6bf45d872e24b9d9ef7cded62b68d32
Autor:
Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Centre and Clinical Cancer Genomics Program, BC Cancer, Vancouver, British Columbia, Canada., Litiere S; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Bidard FC; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France., Cabel L; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France., Dyrskjøt L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Karlovich CA; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Pantel K; Department of Tumor Biology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Petrie J; Canadian Cancer Trials Group, Kingston, Ontario, Canada., Philip R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland., Andrews HS; Friends of Cancer Research, Washington, District of Columbia., Vellanki PJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Tolmeijer SH; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Villalobos Alberu X; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Alfano C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Bogaerts J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Toledo RA; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., de Vries EGE; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Seymour L; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada., Laurie SA; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada., Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Nov 15; Vol. 30 (22), pp. 5034-5041.
Autor:
Ruchalski K; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, USA. kruchalski@mednet.ucla.edu.; 1250 16th Street, Suite 2340, Santa Monica, CA, 90404, USA. kruchalski@mednet.ucla.edu., Anaokar JM; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, USA., Benz MR; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, USA.; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, USA., Dewan R; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, USA., Douek ML; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, USA., Goldin JG; Department of Radiological Sciences, University of California Los Angeles, Los Angeles, USA.
Publikováno v:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Nov 14; Vol. 24 (1), pp. 154. Date of Electronic Publication: 2024 Nov 14.
Autor:
Van Tine BA; Division of Medical Oncology, Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, St. Louis, Missouri.; Department of Pediatric Hematology/Oncology, St Louis Children's Hospital, St. Louis, Missouri., Haarberg S; Division of Medical Oncology, Department of Medicine, School of Medicine, Washington University in St. Louis, St. Louis, Missouri.; Siteman Cancer Center, St. Louis, Missouri.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4552-4553.
Autor:
Kwong TSA; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong S.A.R., Leung HS; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong S.A.R., Mo FKF; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong S.A.R., Tsang YM; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong S.A.R., Lan L; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong S.A.R., P.R. China., Wong LM; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong S.A.R., So TY; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong S.A.R., Hui EP; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong S.A.R., Ma BBY; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir Y.K. Pao Centre for Cancer, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong S.A.R., King AD; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong S.A.R., Ai QYH; Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong S.A.R.; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong S.A.R., P.R. China. Electronic address: hemis.ai@polyu.edu.hk.
Publikováno v:
ESMO open [ESMO Open] 2024 Oct; Vol. 9 (10), pp. 103933. Date of Electronic Publication: 2024 Oct 04.